Adjuvant Therapy for Premenopausal Women With Breast Cancer: Is It Time for Another Paradigm Shift?
- 15 December 2002
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (24) , 4611-4614
- https://doi.org/10.1200/jco.2002.20.24.4611
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Tamoxifen added to adjuvant chemotherapy in premenopausal women with early breast cancer: is it standard practice or still a subject for study?European Journal Of Cancer, 1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Ovarian ablation in early breast cancer: overview of the randomised trialsThe Lancet, 1996
- Premenopausal oopherectomy versus CMF chemotherapy In stage II breast carcinomaThe Lancet, 1993
- Adjuvant ovarian ablation versus CMF chemotherapy in premenopausal women with pathological stage II breast carcinoma: the Scottish trialThe Lancet, 1993
- Ovarian ablation in early breast cancer: phoenix arisen?The Lancet, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breastBreast Cancer Research and Treatment, 1983
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896